16 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
2
6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site.

University of Groningen
41
Discovery and Characterization of BAY-184: A New Potent and Selective Acylsulfonamide-Benzofuran In Vivo-Active KAT6AB Inhibitor.

Bayer AG
26
Discovery of N-(2-oxoethyl) sulfanilamide-derived inhibitors of KAT6A (MOZ) against leukemia by an isostere strategy.

Children's Hospital Affiliated to Zhengzhou University
35
First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8.

Sapienza University of Rome
10
Novel Bisubstrate Inhibitors for Protein N-Terminal Acetyltransferase D.

Purdue University
16
Design, synthesis and biological evaluation of a novel spiro oxazolidinedione as potent p300/CBP HAT inhibitor for the treatment of ovarian cancer.

China Pharmaceutical University
35
Discovery of Highly Potent, Selective, and Orally Efficacious p300/CBP Histone Acetyltransferases Inhibitors.

Chinese Academy of Sciences
10
Enzyme kinetics and inhibition of histone acetyltransferase KAT8.

University of Groningen
17
Identification of novel inhibitors of histone acetyltransferase hMOF through high throughput screening.

Chinese Academy of Sciences
15
Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors.

Chinese Academy of Sciences
30
The relevance of K

University of Groningen
85
ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE 1 (ENPP1) INHIBITORS AND USES THEREOF

Insilico Medicine IP
31
Substituted heterocycles as aldehyde dehydrogenase inhibitors

Kayothera
303
Isoquinolin-3-yl carboxamides and preparation and use thereof

Biosplice Therapeutics
82
Mu opioid receptor modulators

University of California
161
Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

The Institute of Cancer Research: Royal Cancer Hospital